Kindeva Drug Delivery, formerly 3M Drug Delivery Systems, has launched as an independent company following its acquisition by Altaris Capital Partners in a transaction valued at $650 million. As part of the transaction, 3M will retain a 17% minority interest in Kindeva alongside Altaris.   Kindeva is a global contract development and manufacturing organization (CDMO) that specializes in solving complex drug delivery challenges for its pharmaceutical and biotechnology customers. With approximatel...